SG11202109566XA - Method for preparing influenza ha split vaccine - Google Patents

Method for preparing influenza ha split vaccine

Info

Publication number
SG11202109566XA
SG11202109566XA SG11202109566XA SG11202109566XA SG 11202109566X A SG11202109566X A SG 11202109566XA SG 11202109566X A SG11202109566X A SG 11202109566XA SG 11202109566X A SG11202109566X A SG 11202109566XA
Authority
SG
Singapore
Prior art keywords
split vaccine
preparing influenza
influenza
preparing
vaccine
Prior art date
Application number
Other languages
English (en)
Inventor
Yoshimasa Takahashi
Yu Adachi
Manabu Ato
Original Assignee
Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By Director General Of Nat Institute Of Infectious Diseases, Sumitomo Dainippon Pharma Co Ltd filed Critical Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Publication of SG11202109566XA publication Critical patent/SG11202109566XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG11202109566X 2019-03-04 2020-03-03 Method for preparing influenza ha split vaccine SG11202109566XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019038662 2019-03-04
PCT/JP2020/008974 WO2020179797A1 (ja) 2019-03-04 2020-03-03 インフルエンザｈａスプリットワクチンの製造方法

Publications (1)

Publication Number Publication Date
SG11202109566XA true SG11202109566XA (en) 2021-10-28

Family

ID=72337458

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109566X SG11202109566XA (en) 2019-03-04 2020-03-03 Method for preparing influenza ha split vaccine

Country Status (14)

Country Link
EP (1) EP3936147A4 (enrdf_load_stackoverflow)
JP (1) JP7545955B2 (enrdf_load_stackoverflow)
KR (1) KR20210135261A (enrdf_load_stackoverflow)
CN (1) CN114096273A (enrdf_load_stackoverflow)
AU (1) AU2020233456A1 (enrdf_load_stackoverflow)
BR (1) BR112021017310A8 (enrdf_load_stackoverflow)
CA (1) CA3132578A1 (enrdf_load_stackoverflow)
EA (1) EA202192398A1 (enrdf_load_stackoverflow)
IL (1) IL285984A (enrdf_load_stackoverflow)
MX (1) MX2021010685A (enrdf_load_stackoverflow)
MY (1) MY208974A (enrdf_load_stackoverflow)
PH (1) PH12021552094A1 (enrdf_load_stackoverflow)
SG (1) SG11202109566XA (enrdf_load_stackoverflow)
WO (1) WO2020179797A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210034614A (ko) 2018-07-23 2021-03-30 국립감염증연구소장이 대표하는 일본국 인플루엔자 백신을 포함하는 조성물
AU2024264265A1 (en) * 2023-04-26 2025-11-13 Japan Institute For Health Security Anti-influenza antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
WO2010060921A1 (en) * 2008-11-25 2010-06-03 Avir Green Hills Biotechnology Research Development Trade Ag METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
CN102406931B (zh) * 2011-11-25 2014-02-05 成都康华生物制品有限公司 大流行流感病毒裂解疫苗
WO2013173256A2 (en) * 2012-05-16 2013-11-21 Kj Biosciences, Llc New and improved influenza vaccines
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
JP7403733B2 (ja) * 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
KR20210034614A (ko) * 2018-07-23 2021-03-30 국립감염증연구소장이 대표하는 일본국 인플루엔자 백신을 포함하는 조성물

Also Published As

Publication number Publication date
JP7545955B2 (ja) 2024-09-05
EP3936147A1 (en) 2022-01-12
EA202192398A1 (ru) 2021-11-23
PH12021552094A1 (en) 2022-05-30
EP3936147A4 (en) 2022-09-28
MX2021010685A (es) 2021-12-10
BR112021017310A8 (pt) 2022-12-06
JPWO2020179797A1 (enrdf_load_stackoverflow) 2020-09-10
WO2020179797A1 (ja) 2020-09-10
BR112021017310A2 (enrdf_load_stackoverflow) 2021-11-16
MY208974A (en) 2025-06-14
KR20210135261A (ko) 2021-11-12
AU2020233456A1 (en) 2021-10-07
CN114096273A (zh) 2022-02-25
CA3132578A1 (en) 2020-09-10
US20220152191A1 (en) 2022-05-19
IL285984A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
IL281220A (en) Process for preparing vaccine compositions
IL309408A (en) Multivalent flu vaccines
GB202002166D0 (en) Vaccine
GB2572275B (en) Method for preparing Foot-and-Mouth disease vaccine
SG11201911164WA (en) Method for preparing intermediate of 4-methoxypyrrole derivative
EP3708567A4 (en) PROCESS FOR THE PREPARATION OF A BENZOFURANE DERIVATIVE
IL283331A (en) Method for the preparation of n-phenylpyrazole-1-carboxamides
GB202010113D0 (en) Method for preparing miscible nano-pesticide suspension
EP3402514A4 (en) METHOD AND COMPOSITIONS FOR INFLUENZA VACCINATION
SG11202001937TA (en) Method for producing influenza ha split vaccine
PL3429546T3 (pl) Sposób wytwarzania kompozycji medycznej
EP3650536B8 (en) Method for preparing influenza working virus seed stock, method for preparing influenza vaccine using same seed stock, and virus seed stock prepared by same method
SG11202109566XA (en) Method for preparing influenza ha split vaccine
GB202004825D0 (en) Influenza vaccines
GB201714060D0 (en) Method for preparing itraconazole preparation
EP3543236A4 (en) PROCESS FOR THE PREPARATION OF AN AVIBACTAM INTERMEDIATE
ZA202005179B (en) Method for preparing phloroglucinol
IL271512B (en) A method for the preparation of modified 4-aminoindan derivatives
GB201820751D0 (en) Methods for preparing intermediates
IL311964A (en) Multivalent influenza vaccines
EP3858380A4 (en) INACTIVATED WHOLE VIRUS INFLUENZA VACCINE AND METHOD FOR PREPARING IT
GB202114328D0 (en) Influenza vaccines
GB202315888D0 (en) Influenza vaccines
GB202213958D0 (en) Influenza vaccines
GB202208070D0 (en) Influenza vaccines